Neuphoria Therapeutics Inc. Insider Ownership | NEUP

Insider Holdings by Owner

875.33K Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

0.702%

■0% pp QoQ

Shares Held by Insiders

875.33K

filed for Sep 2026

■0.00% QoQ

Shares Outstanding

124.66Mn

124,661,266 shares

Direct Holdings

0

Indirect: 875.33K

Net Shares Traded (QoQ)

0

no net change in Sep 2026

Insiders Holding Shares

1

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Quarter ending 30 Sep, 2026

NEUP's three largest insider shareholders as of September 29, 2026 are Capital Management Lp Lynx1 (TenPercentOwner, 875.33K shares).

A detailed ownership breakdown for Neuphoria Therapeutics is not available at this time.
Per Business Quant data, insider ownership at Neuphoria Therapeutics represents 70.22% of total outstanding shares, amounting to 875.33K shares out of 124.66Mn outstanding.
Neuphoria Therapeutics's count of insider shares amounted to 875.33K as of September 29, 2026.
There were no significant purchases by Neuphoria Therapeutics's insiders in the last 90 days.
Neuphoria Therapeutics had no significant insider sales in the last 90 days.

Form 4 Holdings

Insiders Holding NEUP

Insiders 1

Shares held 875.33K

Of outstanding 0.702%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Capital Management Lp Lynx1	TenPercentOwner	0	875,328	875,328	100.0%	23 Oct, 2025

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

12 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
20 Jan, 2026	Jane Ryan	Director	Acquired A	8,537	$0.00	$0	15,550	Direct
20 Jan, 2026	David Ian Wilson	Director	Acquired A	8,537	$0.00	$0	15,412	Direct
20 Jan, 2026	Alan Fisher	Director	Acquired A	17,073	$0.00	$0	30,731	Direct
20 Jan, 2026	Peter Miles Winston Davies	Director	Acquired A	8,537	$0.00	$0	15,320	Direct
21 Oct, 2025	Capital Management Lp Lynx1	TenPercentOwner	Acquired P	639,110	$5.14	$3.28Mn	875,328	Indirect
27 Aug, 2025	Spyros Papapetropoulos	President And Ceo	Acquired A	34,559	$8.27	$285.80K	74,088	Direct
16 Apr, 2025	Spyros Papapetropoulos	President And Ceo	Acquired A	27,000	$5.16	$139.32K	39,529	Direct
16 Apr, 2025	David Ian Wilson	Director	Acquired A	6,783	$0.00	$0	6,875	Direct
16 Apr, 2025	Spyros Papapetropoulos	President And Ceo	Acquired A	270,000	$5.16	$1.39Mn	282,529	Direct
16 Apr, 2025	Jane Ryan	Director	Acquired A	6,783	$0.00	$0	7,013	Direct
16 Apr, 2025	Alan Fisher	Director	Acquired A	13,566	$0.00	$0	13,658	Direct
16 Apr, 2025	Peter Miles Winston Davies	Director	Acquired A	6,783	$0.00	$0	6,783	Direct

Neuphoria Therapeutics NEUP Insider Ownership